NASSER, Azmi,LAFFONT, Celine Marielle,HEIDBREDER, Christian Arthur
申请号：
EP15828368
公开号：
EP3215223B1
申请日:
2015.11.06
申请国别(地区):
EP
年份:
2020
代理人:
摘要：
The disclosure is directed to sustained-release buprenorphine formulations that provide long-term, therapeutic levels of buprenorphine for the treatment of pain and the maintenance treatment of opioid use disorders, such as opioid dependence.
